Description

NEXGARD XL 25-50 KG (1X3)

Indications

NEXGARD XL is indicated for the treatment and prevention of flea infestations and the control of tick infestations in dogs weighing between 25 to 50 kg. This chewable tablet is effective against various species of ticks, including the Ixodes ricinus (castor bean tick), Rhipicephalus sanguineus (brown dog tick), and Dermacentor variabilis (American dog tick). It is also effective against fleas, providing rapid relief from infestations and preventing re-infestation for a full month.

Mechanism of Action

The active ingredient in NEXGARD XL is afoxolaner, which belongs to the isoxazoline class of compounds. Afoxolaner works by inhibiting the function of the gamma-aminobutyric acid (GABA) and glutamate-gated chloride channels in the nervous system of insects and arachnids. This leads to hyperexcitation of the nervous system, resulting in paralysis and death of the parasites. The rapid onset of action against fleas and ticks makes NEXGARD XL a preferred choice for pet owners seeking effective parasite control.

Pharmacological Properties

NEXGARD XL is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1-2 days. The bioavailability of afoxolaner is high, allowing for effective plasma levels that sustain its efficacy against parasites. The elimination half-life is approximately 2-3 days, which supports the monthly dosing regimen. Afoxolaner is primarily metabolized in the liver and excreted through feces and urine, ensuring minimal accumulation in the body over time.

Contraindications

NEXGARD XL should not be administered to dogs that are hypersensitive to afoxolaner or any of the excipients in the formulation. It is also contraindicated in puppies younger than 8 weeks of age or those weighing less than 25 kg. Caution should be exercised when administering to dogs with a history of seizures, as the safety of afoxolaner in such cases has not been fully established.

Side Effects

While NEXGARD XL is generally well-tolerated, some dogs may experience mild side effects. Commonly reported side effects include vomiting, diarrhea, lethargy, and loss of appetite. These effects are typically transient and resolve without the need for veterinary intervention. In rare cases, more serious side effects such as neurological signs or allergic reactions may occur. If any severe or persistent side effects are observed, pet owners should consult their veterinarian immediately.

Dosage and Administration

The recommended dosage of NEXGARD XL is based on the weight of the dog. For dogs weighing between 25 to 50 kg, one chewable tablet should be administered once a month. It is important to ensure that the tablet is given with food to enhance absorption and efficacy. The chewable form is designed to be palatable, making it easier for pet owners to administer. For optimal results, consistent monthly dosing is essential, especially during peak flea and tick seasons.

Interactions

Currently, there are no known significant drug interactions with NEXGARD XL. However, caution should be exercised when administering other medications that may affect the central nervous system, as afoxolaner’s mechanism of action involves modulation of neurotransmitter pathways. It is advisable for pet owners to inform their veterinarian of any other medications or supplements their dog may be taking prior to starting NEXGARD XL.

Precautions

Before administering NEXGARD XL, it is crucial to conduct a thorough veterinary examination to rule out any underlying health issues. Pet owners should monitor their dogs for any adverse reactions after administration, particularly during the first few doses. Additionally, it is important to keep NEXGARD XL out of reach of children and other pets to prevent accidental ingestion. Pregnant or lactating dogs should only receive this medication under veterinary guidance, as the effects on developing puppies or nursing pups have not been fully studied.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of NEXGARD XL in controlling flea and tick infestations in dogs. In a controlled study, dogs treated with afoxolaner showed a significant reduction in flea counts within 8 hours of administration, with over 90% efficacy maintained throughout the month. Additionally, studies have shown that NEXGARD XL is effective in reducing tick burdens, with a rapid kill rate observed within 24 hours of administration. These studies support the use of NEXGARD XL as a reliable option for parasite control in dogs.

Conclusion

NEXGARD XL 25-50 KG (1X3) is an effective and convenient option for the treatment and prevention of flea and tick infestations in dogs. Its unique mechanism of action, combined with its palatable chewable formulation, makes it a preferred choice among pet owners. With a monthly dosing regimen and a strong safety profile, NEXGARD XL provides peace of mind for dog owners looking to protect their pets from harmful parasites. Always consult with a veterinarian to determine the most appropriate parasite control strategy for your dog.